Carl Zeiss Meditec AG
XETRA:AFX
Carl Zeiss Meditec AG
Total Receivables
Carl Zeiss Meditec AG
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Total Receivables
€582.9m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
2%
|
|
|
Stratec SE
XETRA:SBS
|
Total Receivables
€51.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
7%
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Total Receivables
€63.2m
|
CAGR 3-Years
25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
13%
|
|
|
Siemens Healthineers AG
XETRA:SHL
|
Total Receivables
€6.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Total Receivables
€747m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
|
Sartorius AG
XETRA:SRT
|
Total Receivables
€391.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
10%
|
|
Carl Zeiss Meditec AG
Glance View
Carl Zeiss Meditec AG stands as a beacon in the realm of medical technology, carving a niche through its innovative solutions in ophthalmology and microsurgery. Rooted in the prestigious legacy of the Zeiss Group, this company seamlessly fuses cutting-edge technology with practical medical applications. Its headquarters in Jena, Germany, serve as the crucible for pioneering research and development endeavors, channeling expertise into products that enhance both diagnostic and surgical capabilities. The heart of its operations revolves around creating technological marvels such as optical coherence tomography (OCT) instruments and surgical microscopes, which bring precision and enhanced clarity to the medical field. Through a well-executed blend of R&D and strategic acquisitions, Carl Zeiss Meditec consistently remains at the forefront of medical innovation, ensuring it meets the ever-evolving needs of the healthcare sector. Financially, the company thrives by selling its sophisticated medical devices directly to healthcare professionals, hospitals, and clinics worldwide. Rather than merely creating instruments, Carl Zeiss Meditec's business model is deeply entwined with providing comprehensive workflow solutions and service support, ensuring that medical practitioners extract maximum utility from their investments. By offering not just products but also extensive after-sales service and maintenance, the company builds sustained relationships with its clients, fostering a cycle of trust and repeat business. In addition, its engagement in training and support services enhances user competencies, ensuring the seamless integration of its technology into everyday medical practice and underscoring its commitment to elevating healthcare standards globally. Through this multifaceted approach, Carl Zeiss Meditec solidifies its position as an indispensable ally in the medical community, both as a supplier of state-of-the-art equipment and as a provider of essential healthcare solutions.
See Also
What is Carl Zeiss Meditec AG's Total Receivables?
Total Receivables
582.9m
EUR
Based on the financial report for Dec 31, 2024, Carl Zeiss Meditec AG's Total Receivables amounts to 582.9m EUR.
What is Carl Zeiss Meditec AG's Total Receivables growth rate?
Total Receivables CAGR 10Y
2%
Over the last year, the Total Receivables growth was -55%. The average annual Total Receivables growth rates for Carl Zeiss Meditec AG have been -23% over the past three years , -10% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet